Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 5Recruiting 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 1Melanoma 1Lung Neoplasms 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Radionuclide Imaging × Clear all
NCT06003556 2025-07-04

P-GAP

University of Alberta

Phase 2 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT06666790 2024-10-31

DermaSensor Postmarket Surveillance Study

DermaSensor, Inc.

Phase NA Recruiting
396 enrolled
Dermatologic

Melanoma

NCT06626178 2024-10-03

ARIA

Scientific Institute San Raffaele

Phase NA Recruiting
2,840 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡